Publication | Open Access
26Al tracer experiment by accelerator mass spectrometry and its application to the studies for amyotrophic lateral sclerosis and Alzheimer's disease. I.
31
Citations
1
References
1990
Year
EngineeringBiological Mass SpectrometryNeurochemical BiomarkersAlzheimer's DiseaseAnalytical InstrumentationBioanalysisAnalytical ChemistryToxicologyNeurologyClinical ChemistryNeuropathologyNuclear MedicineTrace ElementAccelerator Mass SpectrometryBiochemistryTrace MetalNeurodegenerative DiseasesAmyotrophic Lateral SclerosisTracer ExperimentMagnetic Resonance SpectroscopyMass SpectrometryProtein Mass SpectrometryNeuroscienceMedicine
Accelerator mass spectrometry (AMS) was applied for 26Al tracer experiment to study the aluminum toxicity and metabolism in rats. To investigate the cause of amyotrophic lateral sclerosis (ALS) and Alzheimer's disease, the aluminum incorporation into the brain (cerebrum) was studied by AMS using 26Al as a tracer. When 26Al was intraperitoneally injected into rats, a considerable amount of 26Al was incorporated into the cerebrum after 5-35 days of the injection.
| Year | Citations | |
|---|---|---|
Page 1
Page 1